Making lemonade out of macro lemons on December 11, 2023 at 7:10 am

Investors will need to adjust portfolios more frequently — we are in a new regime and not going back any time soon

Corporate America Is Testing the Limits of Its Pricing Power on December 11, 2023 at 8:00 am

Firms may struggle to keep profits up if demand slows, but so far they are finding ways to keep margins wide.

Dr Reddy#39;s slumps 7% on US FDA#39;s #39;severe#39; observations for Telangana unit on December 11, 2023 at 5:36 am

Antique Broking estimates the Bachupally unit contributes nearly 30 percent to Dr Reddy#39;s US revenue and adverse observations could lead to a warning letter

Dr Reddy#39;s slumps 7% on US FDA#39;s #39;severe#39; observations for Telangana unit on December 11, 2023 at 5:36 am

Antique Broking estimates the Bachupally unit contributes nearly 30 percent to Dr Reddy#39;s US revenue and adverse observations could lead to a warning letter

SpiceJet says to list shares on NSE on December 11, 2023 at 6:12 am

Shares of the carrier, which is navigating financial turbulence, jumped more than 8 per cent in the morning trade on the BSE.

India’s main engines of economic growth need climate protection on December 11, 2023 at 5:46 am

Urban India to contribute to 75 percent of GDP by 2030. Future proofing cities from climate events such as cyclone Michaung is imperative

Subros scales 52-week high on winning 25-crore order from IRCTC on December 11, 2023 at 4:53 am

Subros#39;s new order from the Indian Railways is for the supply and commissioning of coach roof mounted air-conditioners amounting to Rs 25 crore, the company said in its release. The company#39;s stock price touched a 52-week high of Rs 530.

Analyst Call Tracker: Pessimism in IT continues; AI can redeem IT stocks but not soon enough on December 11, 2023 at 5:10 am

In a recent report, Kotak Securities said that most enterprises are focused on cost reduction; moreover, trends do not indicate the possibility of recovery in discretionary spending in 1HCY24

Zydus Lifesciences inks licensing pact with Daewoong Pharmaceutical on December 11, 2023 at 5:56 am

Zydus Worldwide DMCC, a wholly-owned subsidiary, and Daewoong Pharmaceutical Co Ltd have entered into an exclusive licensing agreement to co-develop and commercialise Leuprolide Acetate for depot suspension in six dosage strengths for the US market, Zydus Lifesciences said in a regulatory filing.

Religare Enterprises gains on buying out MIC Insurance Web Aggregator on December 11, 2023 at 5:13 am

MIC has become a wholly-owned subsidiary of the company. MIC Insurance Web Aggregator is an IRDAI registered insurance web aggregator.